NGENF Nervgen Consolidation continues Possible entry ahead Long

NervGen Pharma Corp.OTC

Description

⋅ Aug 18, 2021 2:05 AM

Nice long ~2 year consolidation is in progress, recent reject from the top side of wedge will present entry opportunities

Entry target ~ 1.15-1.35 (1.25 average)

Interesting medical treatments currently in trials

Long term play